本月全球药品研发进展取得成效的药物共有73个,比上月大幅增加17个。进入注册阶段的有20个,较上月减少14个。其中,5个为全球首次注册的药品,在新市场补充注册的为15个。进入注册前阶段的有12个,较上月增加1个。进入Ⅲ期临床研究阶段的有41个,较上月大幅增加30个。 There were 73 pharmaceuticals that made progress in global pharmaceutical research and development this month, a sharp increase of 17 from the previous month. There were 20 entries in the registration phase, down 14 from the previous month. Among them, 5 were the first drugs registered in the world and 15 were newly registered in the new market. There were 12 before entering the registration phase, an increase from the previous month. Into the phase Ⅲ clinical research phase 41, a substantial increase from the previous month 30.